3rd Annual Opioid Conference
"Serving Families Affected By Opioid Use Disorder"
3rd Annual Opioid Conference
Hosted by: Advanced Nursing Education Workforce for Healthy Delta Moms and Babies University of Tennessee Health Science Center, College of Nursing
Keynote Speaker- Dr. Stephen Loyd
CMO of Cedar Recovery and Vice President of the Tennessee Board of Medical Examiners
We will take a look at how genetics, trauma, and opportunity across the lifespan can contribute in the development of opiate dependency and misuse. We will hear from providers caring for all generations and our discussion will be case based focusing on substance use disorder within families across the lifespan. We will also learn more about the fentanyl crisis and how medication assisted therapy can help improve patient outcomes.
Jennifer Tourville, DNP, Executive Director for UT Institute for Public Service SMART Initiative
Jennifer Anderson, MD, OBGYN provider with LeConte Women's Healthcare, Sevierville, TN and Cedar Recovery in Knoxville, TN.
Jason Yaun, MD, Associate Professor of Pediatrics at UTHSC, Outpatient General Pediatrics Division Chief, and the Medical Director of the ULPS General Pediatrics Clinic.
Clay Jackson, MD, Clinical Assistant Professor of Family Medicine and Psychiatry at UTHSC College of Medicine, where he maintains a private practice in family medicine, and directs the palliative medicine program at the West Cancer Center.
Paul B. Hill, MD, Assistant Professor in the Department of Psychiatry at UTHSC College of Medicine, and Psychiatrist specializing in the treatment of geriatric patients.
Shawn Hamm, MD, Regional Medical Director for Vertava Health and Program Director for the Baptist Memorial Medical Education Addiction Medicine Fellowship Program
Karen Derefinko, PhD, Associate Professor of Preventive Medicine and Associate Professor of Pharmacology, Addiction Science, and Toxicology at UTHSC.
Physicians, Nurses, Pharmacists, Nurse Practitioners, Social Workers, Police Officers, Paramedics, other Community Workers
- Discuss best practices for treating the opiate-dependent pregnant patient and the neonate experiencing neonatal abstinence syndrome.
- Describe the role of genetics and trauma in the development of addiction.
- Identify the risk and benefits of treating opiate addiction with Buprenorphine or Methadone.
- Name the positive predictive factors for weaning to abstinence during pregnancy.
|Lineup of Speakers - 3rd Annual Opioid Conference|
|Keynote: "Trauma: The Driver of Addiction"||Dr. Stephen Loyd|
|"Pregnancy and the Fourth Trimester"||Dr. Jennifer Anderson|
|“ACEs and Resiliency: Their Effect on Health Outcomes in Children"||Dr. Jason Yaun|
|"Unintended Consequences: How Policy, Nosology, and Clinical Phenomenology Sometimes Diverge, Resulting in Patient Harms"||Dr. Clay Jackson|
|Panel Discussion||Dr. Jennifer Tourville, DNP and Morning Presenters|
|Review of Case Study||Dr. Stephen Loyd|
|"Opioid Use Disorders in Older Adults"||Dr. Paul Hill|
|"Medications for Opioid Use Disorder"||Dr. Shawn Hamm, Dr. Karen Derefinko|
|Panel Discussion||Dr. Jennifer Tourville, DNP and Afternoon Presenters|
|Closing Review of Case Study||Dr. Stephen Loyd|
Conflicts of Interest: A Conflict of Interest occurs when an individual has an opportunity to affect educational content about health-care products or services of a commercial interest with which she/he has a financial relationship.
The planners and presenters of this CME/NCPD activity have disclosed no relevant financial relationships with any commercial interests pertaining to this activity.
Commercial Support: No
Noncommercial Sponsor Support: No
Off-label Product Use: This CME/NCPD activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).
AMA Credit Designation: The University of Tennessee College of Medicine (UTCOM) designates this enduring activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCPD Credit Designation: The University of Tennessee Health Science Center, Memphis designates this enduring activity for a maximum of 6.5 hours NCPD credits. To receive full contact credits, you must be view at least 80% of the program, and complete and submit the evaluation at the conclusion of the program.
Continuing Education for Non-Physicians: Certificates of Participation to non-physicians and non-nurses will be awarded credit for participation in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded 1 CEU.
Successful Completion of this CME/Nursing Professional Development Activity:
In order to receive full contact-hour credit for this CME/NCPD activity, you must:
- Be in attendance for at least 80% of the program, and
- Complete and submit the Evaluation through the link provided at the conclusion of the program.
This activity has been planned and implemented in accordance with the accreditation requirements & policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the UTCOM and the University of Tennessee Health Science Center, Memphis College of Nursing. The UTCOM is accredited by the ACCME to provide continuing medical education for physicians
The University of TN Health Science Center College of Nursing, Memphis is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
- 6.50 AMA PRA Category 1 Credit™
- 6.50 ANCC
- 6.50 Attendance